nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—PPP3CA—pons—meningioma	0.125	0.238	CbGeAlD
Tacrolimus—PPP3CA—telencephalic ventricle—meningioma	0.103	0.196	CbGeAlD
Tacrolimus—ABCA5—medulla oblongata—meningioma	0.0287	0.0548	CbGeAlD
Tacrolimus—PPP3CA—brainstem—meningioma	0.0278	0.0531	CbGeAlD
Tacrolimus—ABCA5—spinal cord—meningioma	0.0255	0.0488	CbGeAlD
Tacrolimus—MTOR—brainstem—meningioma	0.0205	0.0392	CbGeAlD
Tacrolimus—ABCA5—cerebellum—meningioma	0.0203	0.0387	CbGeAlD
Tacrolimus—PPP3CA—medulla oblongata—meningioma	0.0194	0.037	CbGeAlD
Tacrolimus—PPP3CA—spinal cord—meningioma	0.0173	0.033	CbGeAlD
Tacrolimus—ABCA5—brain—meningioma	0.0165	0.0315	CbGeAlD
Tacrolimus—PPP3CA—cerebellum—meningioma	0.0137	0.0262	CbGeAlD
Tacrolimus—FKBP1A—medulla oblongata—meningioma	0.0129	0.0246	CbGeAlD
Tacrolimus—MTOR—spinal cord—meningioma	0.0127	0.0244	CbGeAlD
Tacrolimus—FKBP1A—spinal cord—meningioma	0.0115	0.0219	CbGeAlD
Tacrolimus—PPP3CA—brain—meningioma	0.0111	0.0212	CbGeAlD
Tacrolimus—MTOR—cerebellum—meningioma	0.0101	0.0193	CbGeAlD
Tacrolimus—FKBP1A—cerebellum—meningioma	0.00909	0.0174	CbGeAlD
Tacrolimus—ORM1—spinal cord—meningioma	0.00898	0.0172	CbGeAlD
Tacrolimus—MTOR—brain—meningioma	0.00821	0.0157	CbGeAlD
Tacrolimus—FKBP1A—brain—meningioma	0.00738	0.0141	CbGeAlD
Tacrolimus—ALB—brain—meningioma	0.00507	0.00969	CbGeAlD
Tacrolimus—ABCB1—medulla oblongata—meningioma	0.00297	0.00569	CbGeAlD
Tacrolimus—ABCB1—spinal cord—meningioma	0.00265	0.00507	CbGeAlD
Tacrolimus—MTOR—Class I PI3K signaling events mediated by Akt—AKT1—meningioma	0.00225	0.00473	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—PDGFB—meningioma	0.00225	0.00471	CbGpPWpGaD
Tacrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—ERBB2—meningioma	0.00224	0.00469	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—TSHB—meningioma	0.00223	0.00468	CbGpPWpGaD
Tacrolimus—MTOR—TOR Signaling—AKT1—meningioma	0.0022	0.00462	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD34—meningioma	0.00219	0.0046	CbGpPWpGaD
Tacrolimus—MTOR—IL2 signaling events mediated by PI3K—AKT1—meningioma	0.00216	0.00452	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—PDGFB—meningioma	0.00215	0.0045	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—PDGFB—meningioma	0.00211	0.00443	CbGpPWpGaD
Tacrolimus—MTOR—CXCR3-mediated signaling events—AKT1—meningioma	0.00211	0.00443	CbGpPWpGaD
Tacrolimus—ABCB1—cerebellum—meningioma	0.0021	0.00402	CbGeAlD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.0021	0.0044	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CTSL—meningioma	0.00209	0.00439	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—PDGFB—meningioma	0.00202	0.00423	CbGpPWpGaD
Tacrolimus—MTOR—PI-3K cascade—ERBB2—meningioma	0.00201	0.00422	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—PDGFB—meningioma	0.00201	0.00421	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—PDGFB—meningioma	0.002	0.00419	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—PDGFB—meningioma	0.00199	0.00417	CbGpPWpGaD
Tacrolimus—MTOR—ErbB2/ErbB3 signaling events—AKT1—meningioma	0.00199	0.00417	CbGpPWpGaD
Tacrolimus—MTOR—PI3K/AKT activation—ERBB2—meningioma	0.00197	0.00412	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PDGFB—meningioma	0.00196	0.00411	CbGpPWpGaD
Tacrolimus—MTOR—GAB1 signalosome—ERBB2—meningioma	0.00195	0.00409	CbGpPWpGaD
Tacrolimus—MTOR—IFN-gamma pathway—AKT1—meningioma	0.00191	0.00401	CbGpPWpGaD
Tacrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—PTEN—meningioma	0.00191	0.004	CbGpPWpGaD
Tacrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB2—meningioma	0.00191	0.004	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—SMO—meningioma	0.0019	0.00398	CbGpPWpGaD
Tacrolimus—MTOR—ErbB Signaling Pathway—TP53—meningioma	0.00189	0.00396	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—PDGFB—meningioma	0.00187	0.00393	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PDGFB—meningioma	0.00187	0.00393	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—PDGFB—meningioma	0.00187	0.00393	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—PDGFB—meningioma	0.00186	0.00389	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—PDGFB—meningioma	0.00184	0.00386	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—PDGFB—meningioma	0.00183	0.00384	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TP53—meningioma	0.0018	0.00377	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00179	0.00375	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CST3—meningioma	0.00178	0.00374	CbGpPWpGaD
Tacrolimus—MTOR—TSLP Signaling Pathway—AKT1—meningioma	0.00178	0.00373	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TP53—meningioma	0.00175	0.00366	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—PDGFB—meningioma	0.00174	0.00364	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—PDGFB—meningioma	0.00173	0.00363	CbGpPWpGaD
Tacrolimus—MTOR—PI-3K cascade—PTEN—meningioma	0.00172	0.0036	CbGpPWpGaD
Tacrolimus—ABCB1—brain—meningioma	0.00171	0.00327	CbGeAlD
Tacrolimus—MTOR—PI3K/AKT activation—PTEN—meningioma	0.00168	0.00351	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—PDGFB—meningioma	0.00167	0.0035	CbGpPWpGaD
Tacrolimus—MTOR—GAB1 signalosome—PTEN—meningioma	0.00166	0.00349	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PDGFB—meningioma	0.00166	0.00348	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—meningioma	0.00165	0.00347	CbGpPWpGaD
Tacrolimus—MTOR—Wnt Signaling Pathway Netpath—AKT1—meningioma	0.00164	0.00344	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—TP53—meningioma	0.00163	0.00341	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—PTEN—meningioma	0.00162	0.00341	CbGpPWpGaD
Tacrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—meningioma	0.00162	0.00341	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD34—meningioma	0.00158	0.0033	CbGpPWpGaD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—AKT1—meningioma	0.00157	0.00329	CbGpPWpGaD
Tacrolimus—MTOR—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.00157	0.00329	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CTSL—meningioma	0.00157	0.00328	CbGpPWpGaD
Tacrolimus—MTOR—AMPK Signaling—TP53—meningioma	0.00155	0.00325	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00151	0.00316	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—ERBB2—meningioma	0.0015	0.00316	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CTSL—meningioma	0.0015	0.00315	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—AKT1—meningioma	0.00147	0.00309	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00144	0.00302	CbGpPWpGaD
Tacrolimus—MTOR—IL4-mediated signaling events—AKT1—meningioma	0.00143	0.00299	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—ERBB2—meningioma	0.00142	0.00297	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AP1B1—meningioma	0.00142	0.00297	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.00141	0.00296	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CST3—meningioma	0.00138	0.0029	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00137	0.00288	CbGpPWpGaD
Tacrolimus—MTOR—mTOR signaling pathway—AKT1—meningioma	0.00136	0.00285	CbGpPWpGaD
Tacrolimus—MTOR—TSH signaling pathway—AKT1—meningioma	0.00136	0.00285	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—ERBB2—meningioma	0.00135	0.00284	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00135	0.00284	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—ERBB2—meningioma	0.00135	0.00282	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—ERBB2—meningioma	0.00135	0.00282	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—ERBB2—meningioma	0.00134	0.00281	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—ERBB2—meningioma	0.00133	0.0028	CbGpPWpGaD
Tacrolimus—MTOR—Regulation of Telomerase—AKT1—meningioma	0.00133	0.00278	CbGpPWpGaD
Tacrolimus—MTOR—Costimulation by the CD28 family—AKT1—meningioma	0.00133	0.00278	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TSHB—meningioma	0.00132	0.00276	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	0.00131	0.00276	CbGpPWpGaD
Tacrolimus—MTOR—SREBP signalling—AKT1—meningioma	0.00131	0.00275	CbGpPWpGaD
Tacrolimus—MTOR—AMPK Signaling—AKT1—meningioma	0.00131	0.00275	CbGpPWpGaD
Tacrolimus—MTOR—Disease—AP1B1—meningioma	0.00131	0.00274	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—PTEN—meningioma	0.00128	0.00269	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—PDGFB—meningioma	0.00128	0.00267	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—ERBB2—meningioma	0.00125	0.00263	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—ERBB2—meningioma	0.00125	0.00263	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00125	0.00263	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—ERBB2—meningioma	0.00124	0.00261	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00123	0.00258	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—PTEN—meningioma	0.00123	0.00257	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—ERBB2—meningioma	0.00123	0.00257	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—AKT1—meningioma	0.00123	0.00257	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00122	0.00256	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—PTEN—meningioma	0.00121	0.00255	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—PTEN—meningioma	0.00121	0.00253	CbGpPWpGaD
Tacrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—meningioma	0.00116	0.00244	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—ERBB2—meningioma	0.00116	0.00243	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—PTEN—meningioma	0.00116	0.00243	CbGpPWpGaD
Tacrolimus—PPP3CA—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.00116	0.00243	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—PTEN—meningioma	0.00115	0.00242	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—PTEN—meningioma	0.00115	0.00241	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—PTEN—meningioma	0.00115	0.00241	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—PTEN—meningioma	0.00114	0.0024	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—PTEN—meningioma	0.00114	0.00238	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.00112	0.00235	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SMO—meningioma	0.00112	0.00235	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00112	0.00235	CbGpPWpGaD
Tacrolimus—MTOR—CXCR4-mediated signaling events—AKT1—meningioma	0.00112	0.00235	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—ERBB2—meningioma	0.00112	0.00234	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.00111	0.00233	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—meningioma	0.00111	0.00233	CbGpPWpGaD
Tacrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	0.0011	0.0023	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by WNT in cancer—AKT1—meningioma	0.00108	0.00226	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PGR—meningioma	0.00107	0.00225	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—PTEN—meningioma	0.00107	0.00224	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00107	0.00224	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—PTEN—meningioma	0.00107	0.00224	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—PTEN—meningioma	0.00106	0.00222	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—PTEN—meningioma	0.00105	0.0022	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—HES1—meningioma	0.00105	0.0022	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—PTEN—meningioma	0.00105	0.00219	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00103	0.00216	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TSHB—meningioma	0.00102	0.00214	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—PTEN—meningioma	0.00099	0.00208	CbGpPWpGaD
Tacrolimus—MTOR—PI-3K cascade—AKT1—meningioma	0.000989	0.00207	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PDGFB—meningioma	0.000971	0.00204	CbGpPWpGaD
Tacrolimus—MTOR—PI3K/AKT activation—AKT1—meningioma	0.000966	0.00203	CbGpPWpGaD
Tacrolimus—MTOR—GAB1 signalosome—AKT1—meningioma	0.000958	0.00201	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD34—meningioma	0.000956	0.002	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—PTEN—meningioma	0.000953	0.002	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.000948	0.00199	CbGpPWpGaD
Tacrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	0.000936	0.00196	CbGpPWpGaD
Tacrolimus—MTOR—ErbB1 downstream signaling—AKT1—meningioma	0.000936	0.00196	CbGpPWpGaD
Tacrolimus—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.000923	0.00193	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.000922	0.00193	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CTSL—meningioma	0.000912	0.00191	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PDGFB—meningioma	0.000897	0.00188	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by Wnt—AKT1—meningioma	0.000887	0.00186	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—AKT1—meningioma	0.000871	0.00183	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SMO—meningioma	0.000869	0.00182	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—ERBB2—meningioma	0.000855	0.00179	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALAD—meningioma	0.000842	0.00176	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PGR—meningioma	0.000833	0.00175	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—meningioma	0.000829	0.00174	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HES1—meningioma	0.000813	0.00171	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TP53—meningioma	0.00079	0.00166	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CST3—meningioma	0.000777	0.00163	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00077	0.00161	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—AKT1—meningioma	0.00074	0.00155	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HES1—meningioma	0.000734	0.00154	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—PTEN—meningioma	0.000729	0.00153	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PDGFB—meningioma	0.000727	0.00153	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—AKT1—meningioma	0.000727	0.00152	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—AKT1—meningioma	0.000708	0.00148	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—AKT1—meningioma	0.0007	0.00147	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PDGFB—meningioma	0.000698	0.00146	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—AKT1—meningioma	0.000696	0.00146	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PDGFB—meningioma	0.000695	0.00146	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—AKT1—meningioma	0.000668	0.0014	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—AKT1—meningioma	0.000665	0.00139	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—AKT1—meningioma	0.000662	0.00139	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.000662	0.00139	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—AKT1—meningioma	0.000659	0.00138	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—AKT1—meningioma	0.000655	0.00137	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—ERBB2—meningioma	0.000651	0.00137	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000646	0.00135	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PDGFB—meningioma	0.000628	0.00132	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—AKT1—meningioma	0.000617	0.00129	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000617	0.00129	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—AKT1—meningioma	0.000617	0.00129	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—AKT1—meningioma	0.000611	0.00128	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALAD—meningioma	0.000608	0.00128	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—AKT1—meningioma	0.000606	0.00127	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—AKT1—meningioma	0.000603	0.00126	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—ERBB2—meningioma	0.000601	0.00126	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	0.000584	0.00123	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TSHB—meningioma	0.000575	0.0012	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—AKT1—meningioma	0.000571	0.0012	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HES1—meningioma	0.000569	0.00119	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PTEN—meningioma	0.000555	0.00116	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—AKT1—meningioma	0.000549	0.00115	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PLAUR—meningioma	0.000549	0.00115	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000546	0.00115	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TSHB—meningioma	0.000542	0.00114	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—meningioma	0.00053	0.00111	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ALAD—meningioma	0.000524	0.0011	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTEN—meningioma	0.000513	0.00107	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000508	0.00107	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SMO—meningioma	0.000489	0.00102	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—ERBB2—meningioma	0.000487	0.00102	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PDGFB—meningioma	0.000487	0.00102	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PGR—meningioma	0.000468	0.000982	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ERBB2—meningioma	0.000468	0.000982	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—ERBB2—meningioma	0.000466	0.000977	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALAD—meningioma	0.000459	0.000963	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HES1—meningioma	0.000457	0.000959	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000433	0.000909	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PDGFB—meningioma	0.000424	0.000888	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ERBB2—meningioma	0.000421	0.000883	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—AKT1—meningioma	0.00042	0.000881	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PTEN—meningioma	0.000416	0.000872	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PTEN—meningioma	0.000399	0.000837	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTEN—meningioma	0.000397	0.000833	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PDGFB—meningioma	0.000397	0.000832	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TSHB—meningioma	0.000392	0.000822	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PDGFB—meningioma	0.000391	0.00082	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PLAU—meningioma	0.000385	0.000808	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PTEN—meningioma	0.000359	0.000753	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—AKT1—meningioma	0.00035	0.000734	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TSHB—meningioma	0.000338	0.000708	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB2—meningioma	0.000326	0.000684	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HES1—meningioma	0.00032	0.000671	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—AKT1—meningioma	0.00032	0.000671	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TSHB—meningioma	0.000296	0.00062	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000296	0.00062	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—AKT1—meningioma	0.000295	0.000619	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB2—meningioma	0.000284	0.000595	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALAD—meningioma	0.000283	0.000593	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTEN—meningioma	0.000278	0.000584	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PDGFB—meningioma	0.000274	0.000574	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB2—meningioma	0.000262	0.00055	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000254	0.000532	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00025	0.000524	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—meningioma	0.000245	0.000514	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PTEN—meningioma	0.000242	0.000508	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—AKT1—meningioma	0.00024	0.000502	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—AKT1—meningioma	0.00023	0.000482	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—AKT1—meningioma	0.000229	0.00048	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTEN—meningioma	0.000224	0.000469	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AKT1—meningioma	0.000207	0.000434	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000207	0.000433	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—meningioma	0.00019	0.000398	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB2—meningioma	0.000184	0.000385	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TSHB—meningioma	0.000182	0.000382	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AKT1—meningioma	0.00016	0.000336	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTEN—meningioma	0.000157	0.000328	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—meningioma	0.000155	0.000325	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTEN—meningioma	0.000148	0.00031	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AKT1—meningioma	0.00014	0.000293	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—AKT1—meningioma	0.000131	0.000274	CbGpPWpGaD
Tacrolimus—MTOR—Disease—AKT1—meningioma	0.000129	0.00027	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—meningioma	0.000107	0.000224	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTEN—meningioma	0.000107	0.000224	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTEN—meningioma	9.2e-05	0.000193	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKT1—meningioma	9.02e-05	0.000189	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AKT1—meningioma	8.52e-05	0.000179	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTEN—meningioma	8.06e-05	0.000169	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKT1—meningioma	6.16e-05	0.000129	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKT1—meningioma	5.3e-05	0.000111	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTEN—meningioma	4.97e-05	0.000104	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKT1—meningioma	4.64e-05	9.74e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKT1—meningioma	2.86e-05	6e-05	CbGpPWpGaD
